TGF-β-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Cell Science

• Publication date

  2005-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1242/jcs.02587PMID 16179614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiostatin and Angiostatin-related Proteins

  2004cited by this paper
• HERC5, a HECT E3 ubiquitin ligase tightly regulated in LPS activated endothelial cells

  2004cited by this paper
• Urokinase as a Multidomain Protein and Polyfunctional Cell Regulator

  2004cited by this paper
• Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells.

  2004cited by this paper
• Mannose 6-phosphate receptors: new twists in the tale

  2003cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• The Voltage-dependent Anion Channel Is a Receptor for Plasminogen Kringle 5 on Human Endothelial Cells*

  2003cited by this paper
• Generation of Biologically Active Angiostatin Kringle 1–3 by Activated Human Neutrophils1

  2002influential reference
• The N Terminus of Mannose 6-Phosphate/Insulin-like Growth Factor 2 Receptor in Regulation of Fibrinolysis and Cell Migration*

  2002influential reference
• Matrix metalloproteinases and angiogenesis

  2002cited by this paper
• Plasmin-induced Migration of Endothelial Cells

  2002cited by this paper
• Kinetics of thrombomodulin release and endothelial cell injury by neutrophil‐derived proteases and oxygen radicals

  2002cited by this paper
• Extracellular Proteolysis and Angiogenesis

  2001cited by this paper
• Specific Interaction of Angiostatin with Integrin αvβ3 in Endothelial Cells*

  2001cited by this paper
• Angiostatin Generation by Cathepsin D Secreted by Human Prostate Carcinoma Cells*

  2000influential reference
• Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.

  2000cited by this paper
• Specific proteolysis of human plasminogen by a 24 kDa endopeptidase from a novel Chryseobacterium Sp.

  2000cited by this paper
• Matrix metalloproteinases and angiogenesis

  2000cited by this paper
• The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

  1999cited by this paper
• Vascular cell apoptosis: cell type-specific modulation by transforming growth factor-beta1 in endothelial cells versus smooth muscle cells.

  1999cited by this paper
• M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.

  1999influential reference
• M6P/IGFII‐receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor‐β1

  1999influential reference
• A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices.

  1999cited by this paper
• Endostatin Induces Endothelial Cell Apoptosis*

  1999cited by this paper
• Angiostatin binds ATP synthase on the surface of human endothelial cells.

  1999cited by this paper
• Thrombospondin-1 Is a Major Activator of TGF-β1 In Vivo

  1998cited by this paper
• Evidence for the Expression of Urokinase-type Plasminogen Activator by Human Venous Endothelial Cells In Vivo

  1998cited by this paper
• Multiple forms of angiostatin induce apoptosis in endothelial cells.

  1998cited by this paper
• Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.

  1998cited by this paper
• Matrix metalloproteinases generate angiostatin: effects on neovascularization.

  1998influential reference
• Overexpression of transforming growth factor beta1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia.

  1998cited by this paper
• PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate

  1998cited by this paper
• Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

  1998cited by this paper
• Macrophage Formation of Angiostatin during Inflammation

  1998cited by this paper
• Mechanisms of angiogenesis

  1997cited by this paper
• Kringle 5 of Plasminogen is a Novel Inhibitor of Endothelial Cell Growth*

  1997cited by this paper
• Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern.

  1996cited by this paper
• REGULATION AND ROLE OF UROKINASE PLASMINOGEN ACTIVATOR IN VASCULAR REMODELLING

  1996cited by this paper
• Apoptosis of endothelial cells induced by the neutrophil serine proteases proteinase 3 and elastase.

  1996cited by this paper
• Blood vessel formation: what is its molecular basis?

  1996cited by this paper
• Characterization of latent TGF-beta activation by murine peritoneal macrophages.

  1995cited by this paper
• Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis.

  1995cited by this paper
• Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

  1994cited by this paper
• Endothelial cells exhibiting angiogenesis in vitro proliferate in response to TGF‐β1

  1993cited by this paper
• Basic fibroblast growth factor and transforming growth factor beta‐1: Synergistic mediators of angiogenesis in vitro

  1993cited by this paper
• Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

  1992cited by this paper
• Modulation of vascular cell behavior by transforming growth factors β

  1992cited by this paper
• Lung capillary endothelial cells produce and secrete urokinase-type plasminogen activator.

  1992cited by this paper
• Directed plasminogen activation at the surface of normal and malignant cells.

  1991influential reference
• Characterization of the activation of latent TGF-beta by co-cultures of endothelial cells and pericytes or smooth muscle cells: a self- regulating system

  1990cited by this paper
• Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin

  1990cited by this paper
• TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

  1990cited by this paper
• Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3.

  1990cited by this paper
• TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights

  1990cited by this paper
• Transforming growth factor β‐1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells

  1989cited by this paper
• Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

  1989cited by this paper
• An elastase-dependent pathway of plasminogen activation.

  1989cited by this paper
• Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells.

  1988cited by this paper
• Production of Plasminogen Activators and Inhibitor by Serially Propagated Endothelial Cells from Adult Human Blood Vessels

  1987cited by this paper
• The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells

  1987cited by this paper
• Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.

  1986cited by this paper
• Characterization of a plasminogen activator secreted by cultured bovine aortic endothelial cells.

  1982cited by this paper
• Mini-plasminogen: a mechanism for leukocyte modulation of plasminogen activation by urokinase.

  1981cited by this paper

• Modulation of TGF-β signaling new approaches toward kidney disease and fibrosis therapy

  2025cites this paper
• From renal development to pathology: An analysis of the multilevel role of insulin-like growth factor 2 (Review)

  2025cites this paper
• Mannose-tagged rhamnosomes for active targeting of pterostilbene in acute lung injury

  2025cites this paper
• Butyrate-preconditioned human adipose-derived stem cell-conditioned medium enhances myocardial perfusion after infarction

  2025cites this paper
• Platelets and platelet-derived microvesicles: Phenotype, content, impact on endothelial cells

  2025cites this paper
• Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance

  2023cites this paper
• Insulin-like growth factor 2 receptor is a key immune-related gene that is correlated with a poor prognosis in patients with triple-negative breast cancer: A bioinformatics analysis

  2022cites this paper
• Orthobiologics for the Treatment of Achilles Tendinopathy

  2022cites this paper
• Androgen receptor-mediated paracrine signaling induces regression of blood vessels in the dermal papilla in androgenetic alopecia.

  2022cites this paper
• New insights in ARDS pathogenesis

  2022cites this paper
• Inflammation in Metabolic Cardiomyopathy

  2021cites this paper
• Biologics in the Treatment of Achilles Tendon.

  2021cites this paper
• Longitudinal relationships between polycyclic aromatic hydrocarbons exposure and heart rate variability: Exploring the role of transforming growth factor-β in a general Chinese population.

  2021cites this paper
• Tissue plasminogen activator is a ligand of cation-independent mannose 6-phosphate receptor and consists of glycoforms that contain mannose 6-phosphate

  2021cites this paper
• TGF-β Signaling: A Therapeutic Target to Reinstate Regenerative Plasticity in Vascular Dementia?

  2020cites this paper
• Biologics in the Treatment of Achilles Tendon Pathologies.

  2019cites this paper
• The mannose 6‐phosphate/insulin‐like growth factor 2 receptor mediates plasminogen‐induced efferocytosis

  2019cites this paper
• Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways

  2019cites this paper
• Lactoferrin is a natural inhibitor of plasminogen activation

  2018cites this paper
• Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells.

  2018cites this paper
• Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances

  2018cites this paper
• Unravelling novel functions of the endosomal transporter mannose 6-phosphate/insulin-like growth factor receptor (CD222) in health and disease: An emerging regulator of the immune system.

  2017cites this paper
• Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure

  2016cites this paper
• The role of growth factors in tendon stimulation

  2015cites this paper
• Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance.

  2015cites this paper
• The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure

  2015cites this paper
• The mannose-6-phosphate analogue, PXS64, inhibits fibrosis via TGF-β1 pathway in human lung fibroblasts.

  2015cites this paper
• The role of TGFβ1 and LRG1 in cardiac remodelling and heart failure

  2015cites this paper
• PLATELET ANGIOGENIC ACTIVITIES AND THEIR REGULATION ON ENDOTHELIAL PROGENITOR CELL FUNCTIONS

  2015cites this paper
• mannose-6-phosphate analogue , PXS 64 , inhibits fibrosis via GF-1 pathway in human lung fibroblasts

  2015cites this paper
• The growth factors involved in flexor tendon repair and adhesion formation

  2014cites this paper
• Reduction of Tendon Adhesions following Administration of Adaprev, a Hypertonic Solution of Mannose-6-Phosphate: Mechanism of Action Studies

  2014cites this paper
• University of Birmingham Reduction of tendon adhesions following administration of adaprev, a hypertonic solution of mannose-6-phosphate

  2014cites this paper
• Endothelial cells and the IGF system.

  2014cites this paper
• Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells

  2013cites this paper
• Do membrane proteins cluster without binding between molecules

  2012cites this paper
• Dissecting Mannose 6-Phosphate-Insulin-like Growth Factor 2 Receptor Complexes That Control Activation and Uptake of Plasminogen in Cells*

  2012cites this paper
• The Interferon Stimulated Gene 12 Inactivates Vasculoprotective Functions of NR4A Nuclear Receptors

  2012cites this paper
• Isolation of primitive endoderm, mesoderm, vascular endothelial and trophoblast progenitors from human pluripotent stem cells

  2012cites this paper
• Soluble M6P/IGF2R Released by TACE Controls Angiogenesis via Blocking Plasminogen Activation

  2011cites this paper
• Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.

  2011cites this paper
• Extravasale Proteolyse: Funktion und Interaktion der Faktoren des fibrinolytischen Systems

  2010cites this paper
• Residues essential for plasminogen binding by the cation-independent mannose 6-phosphate receptor.

  2010influential citation
• uPA, uPAR and TGFβ₁ expression during early and late post myocardial infarction period in rat myocardium.

  2010cites this paper
• Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes.

  2009cites this paper
• Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure.

  2009cites this paper
• Senescence-messaging secretome: SMS-ing cellular stress

  2009cites this paper
• Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.

  2009cites this paper
• Integrative Computational Identifications of the Signaling Pathway Network Related to TNF-alpha Stimulus in Vascular Endothelial Cells

  2009cites this paper
• High‐affinity ligand binding by wild‐type/mutant heteromeric complexes of the mannose 
6‐phosphate/insulin‐like growth factor II receptor

  2009cites this paper
• Regulation of expression of zebrafish (Danio rerio) insulin‐like growth factor 2 receptor: implications for evolution at the IGF2R locus

  2009cites this paper
• Primary aldosteronism can alter peripheral levels of transforming growth factor β and tumor necrosis factor α

  2009cites this paper
• Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.

  2008cites this paper
• Mechanisms of TGF-β-Induced Apoptosis in Cancer Cells

  2008cites this paper
• TGF-β Availability: Latent TGF-β and Latent TGF-β Binding Proteins

  2008cites this paper
• Cell Surface-expressed Cation-independent Mannose 6-Phosphate Receptor (CD222) Binds Enzymatically Active Heparanase Independently of Mannose 6-Phosphate to Promote Extracellular Matrix Degradation*

  2008cites this paper
• Review of the activation of TGF‐β in immunity

  2008cites this paper
• Impact of plasminogen on an in vitro wound healing model based on a perfusion cell culture system

  2008cites this paper
• Kinetic Analysis of Ligand-Receptor Complex Formation with the Aid of Computer Simulation

  2007cites this paper
• Clustering of membrane proteins in the pre-stimulation stage is required for signal transduction: a computer analysis

  2007cites this paper
• uPAR – uPA – PAI-1 interactions and signaling: A vascular biologist’s view

  2007cites this paper
• Differential gene expression in response to transforming growth factor‐β1 by fetal and postnatal dermal fibroblasts

  2007cites this paper
• Survey of the year 2005 commercial optical biosensor literature

  2006cites this paper
• The role of transforming growth factor-β in atherosclerosis

  2006cites this paper
• The role of transforming growth factor-beta in atherosclerosis.

  2006cites this paper
• Survey of the year 2003 commercial optical biosensor literature

  2005cites this paper
• ТРОМБОЦИТЫ И ИХ МИКРОВЕЗИКУЛЫ: ФЕНОТИП, СОСТАВ, ВЛИЯНИЕ НА ЭНДОТЕЛИЙ

  year unknowncites this paper